Cargando…
Δ(9)-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
PURPOSE: It has been known for nearly 50 years that cannabis and the psychoactive constituent Δ(9)-tetrahydrocannabinol (THC) reduce intraocular pressure (IOP). Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a major cause of blindness. THC likely acts via one of the kno...
Autores principales: | Miller, Sally, Daily, Laura, Leishman, Emma, Bradshaw, Heather, Straiker, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295937/ https://www.ncbi.nlm.nih.gov/pubmed/30550613 http://dx.doi.org/10.1167/iovs.18-24838 |
Ejemplares similares
-
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2016) -
Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model
por: Miller, Sally, et al.
Publicado: (2016) -
A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent Manner
por: Miller, Sally, et al.
Publicado: (2017) -
Development of a Δ(9)-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
por: Adelli, Goutham R., et al.
Publicado: (2017) -
Chronic Adolescent Δ(9)-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment
por: Murphy, Michelle, et al.
Publicado: (2017)